Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Glaukos Corp (GKOS)

Glaukos Corp (GKOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,838,786
  • Shares Outstanding, K 57,435
  • Annual Sales, $ 383,480 K
  • Annual Income, $ -146,370 K
  • EBIT $ -88 M
  • EBITDA $ -52 M
  • 60-Month Beta 0.67
  • Price/Sales 14.37
  • Price/Cash Flow N/A
  • Price/Book 9.25

Options Overview Details

View History
  • Implied Volatility 61.60% (-1.09%)
  • Historical Volatility 47.09%
  • IV Percentile 69%
  • IV Rank 42.93%
  • IV High 92.88% on 04/11/25
  • IV Low 38.07% on 08/12/25
  • Expected Move (DTE 21) 12.06 (10.06%)
  • Put/Call Vol Ratio 0.08
  • Today's Volume 26
  • Volume Avg (30-Day) 98
  • Put/Call OI Ratio 0.56
  • Today's Open Interest 2,009
  • Open Int (30-Day) 1,925
  • Expected Range 107.86 to 131.98

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.23
  • Number of Estimates 7
  • High Estimate -0.09
  • Low Estimate -0.30
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +42.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
93.96 +27.66%
on 01/14/26
130.23 -7.89%
on 01/22/26
+5.71 (+5.00%)
since 12/30/25
3-Month
80.90 +48.26%
on 11/07/25
130.23 -7.89%
on 01/22/26
+32.15 (+36.62%)
since 10/30/25
52-Week
73.16 +63.96%
on 10/28/25
161.78 -25.86%
on 02/19/25
-37.80 (-23.96%)
since 01/30/25

Most Recent Stories

More News
Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 119.64 (+0.48%)
Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17

Conference Call and Webcast Scheduled for 1:30 p.m. PT

GKOS : 119.64 (+0.48%)
Stock Indexes Settle Lower on Tech Weakness

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -0.53%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.07%. March...

MSTR : 149.13 (+4.15%)
GOOGL : 338.97 (+0.21%)
MPC : 175.11 (-0.36%)
GLXY : 28.32 (-5.47%)
RIVN : 14.68 (-3.23%)
ABNB : 129.33 (-1.85%)
COIN : 194.36 (-2.42%)
TGTX : 29.45 (-1.83%)
OXY : 45.35 (-0.15%)
TSLA : 434.15 (+4.22%)
^BTCUSD : 83,879.98 (-0.66%)
SPY : 692.14 (-0.27%)
Stocks Retreat as Big Tech Falters

The S&P 500 Index ($SPX ) (SPY ) today is down -0.96%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.57%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.53%. March E-mini S&P futures...

MSTR : 149.13 (+4.15%)
GOOGL : 338.97 (+0.21%)
MPC : 175.11 (-0.36%)
GLXY : 28.32 (-5.47%)
RIVN : 14.68 (-3.23%)
COIN : 194.36 (-2.42%)
TGTX : 29.45 (-1.83%)
OXY : 45.35 (-0.15%)
TSLA : 434.15 (+4.22%)
^BTCUSD : 83,879.98 (-0.66%)
SPY : 692.14 (-0.27%)
META : 717.60 (-2.81%)
Stocks Pressured by Tech Weakness and Iran Tensions

The S&P 500 Index ($SPX ) (SPY ) today is down -0.75%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.46%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.22%. March E-mini S&P futures...

AMAT : 324.14 (-5.04%)
GOOGL : 338.97 (+0.21%)
MPC : 175.11 (-0.36%)
AVGO : 331.22 (+0.15%)
CVX : 176.35 (+3.01%)
FN : 488.74 (-1.52%)
RIVN : 14.68 (-3.23%)
$IUXX : 25,514.19 (-1.43%)
ZNH26 : 111-265 (-0.03%)
MSFT : 428.77 (-1.09%)
TGTX : 29.45 (-1.83%)
OXY : 45.35 (-0.15%)
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 119.64 (+0.48%)
Glaukos Announces Participation in J.P. Morgan Healthcare Conference

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced...

GKOS : 119.64 (+0.48%)
Glaukos Announces Participation in Upcoming Investor Conferences

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced...

GKOS : 119.64 (+0.48%)
Glaukos: Q3 Earnings Snapshot

Glaukos: Q3 Earnings Snapshot

GKOS : 119.64 (+0.48%)
Glaukos Announces Third Quarter 2025 Financial Results

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 119.64 (+0.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an...

See More

Key Turning Points

3rd Resistance Point 127.72
2nd Resistance Point 125.83
1st Resistance Point 122.45
Last Price 119.64
1st Support Level 117.18
2nd Support Level 115.29
3rd Support Level 111.91

See More

52-Week High 161.78
Fibonacci 61.8% 127.93
Last Price 119.64
Fibonacci 50% 117.47
Fibonacci 38.2% 107.01
52-Week Low 73.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar